Biotech Values

[biomaven0]

<BDEL>

I've followed them. Key question here is if they can get the FDA to ignore some of the data from one of their India-based trials. If you throw out that data, then their trial succeeded, if not, it failed to show non-inferiority.

The company apparently company claims they know the reason for the bad Indian data - they say some blood samples were transported by land, unrefrigerated.

If the FDA believes them and is accommodating, then the stock is a buy. I don't really have enough information to make an informed decision.

(No current position, but I'm tempted).

Peter